The industry research report presents a detailed analysis and segmentation of the global intrauterine devices market by product type (hormonal intrauterine device and copper intrauterine device) and by geography (APAC, Americas, and EMEA). It also presents an analysis of the key vendors like Actavis, Bayer, and Teva Pharmaceutical.
Technavio has released updated information on the urology market, with the publication of its new market research report, global IUD market. The global intrauterine devices (IUDs) market is expected to grow at a CAGR of more than 3% between 2015 and 2019. Increased prevalence of Sexually transmitted disease (STDs) and the growing use of contraceptive devices are major factors boosting this market’s growth. EMEA is the largest market for IUDs, accounting for 43% of the overall market revenue. The region will dominate the global market over the next four years due to growing support from the government and the augmented formation of strategic alliances between global and local companies.
“Increased occurrence of unintended pregnancies is a major factor propelling this market’s growth. Unwanted pregnancies have increased the abortion risks and healthcare expenditure consequently. Around 60% of the pregnancies now-a-days have turned out to be unintended or mistimed. However, the use of effective contraception devices can prevent 90% of abortion-related and 20% of pregnancy-related morbidity and mortality cases. Various governments and NGOs like APCOC, ESC, FIGO, and IPPF are encouraging the use of IUDs and birth control methods to avoid unplanned pregnancies across the world,” says Imran Mushtaq, Lead Analyst, Healthcare & Lifesciences, Technavio Research.
Increased awareness about family planning has increased the adoption of birth control devices, especially IUDs. These devices are long-acting reversible contraceptive devices lasting up to 12 years. IUDs have the highest efficacy rate in controlling pregnancies. Vendors have come up with various improved IUD versions such as the fourth generation IUDs with a life span of 25 years. They can be used as an ultra-long, efficient and reversible long-acting reversible contraceptives (LARC).
The leading vendors in the global intrauterine devices market include Actavis, Bayer, and Teva Pharmaceutical. This market is extremely competitive and is vulnerable to various technical and research challenges, which facilitates inorganic growth within the market. Local and regional vendors in this market compete on the basis of product price, quality, innovation, service, reputation, distribution, and promotion to gain maximum market traction during the forecast period.
A more detailed analysis is available in the Technavio report, Global Intrauterine Devices Market 2015-2019.
We can customize this reports by other regions and specific segments upon request.
Other Related Reports:
- Global Urinary Catheters Market 2015-2019
- Urinary Incontinence Products Market in the US 2015-2019
- Global Urinary Incontinence Products Market 2015-2019
- Global Urology Devices Market 2014-2018
Further Reading:
